NantHealth (NASDAQ:NH) Stock Rating Lowered by ValuEngine

Share on StockTwits

ValuEngine downgraded shares of NantHealth (NASDAQ:NH) from a sell rating to a strong sell rating in a research report released on Tuesday, ValuEngine reports.

A number of other research analysts also recently commented on NH. Zacks Investment Research downgraded NantHealth from a buy rating to a hold rating in a report on Thursday, August 15th. Cowen set a $1.00 price objective on NantHealth and gave the stock a buy rating in a report on Monday, August 26th.

NASDAQ:NH opened at $1.07 on Tuesday. The firm has a 50-day moving average of $0.87 and a two-hundred day moving average of $0.66. The stock has a market cap of $130.53 million, a P/E ratio of -0.61 and a beta of 1.54. NantHealth has a 1-year low of $0.45 and a 1-year high of $1.96.

NantHealth (NASDAQ:NH) last announced its earnings results on Thursday, November 7th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.07) by ($0.08). NantHealth had a negative return on equity of 10,106.10% and a negative net margin of 105.82%. The business had revenue of $22.36 million for the quarter, compared to analysts’ expectations of $23.40 million. On average, analysts predict that NantHealth will post -0.46 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Tower Research Capital LLC TRC lifted its holdings in NantHealth by 778.8% during the 3rd quarter. Tower Research Capital LLC TRC now owns 45,988 shares of the company’s stock worth $33,000 after buying an additional 40,755 shares during the last quarter. Miracle Mile Advisors LLC grew its position in shares of NantHealth by 154.2% in the 2nd quarter. Miracle Mile Advisors LLC now owns 75,000 shares of the company’s stock worth $39,000 after acquiring an additional 45,500 shares in the last quarter. Finally, Paloma Partners Management Co increased its holdings in shares of NantHealth by 436.1% in the 2nd quarter. Paloma Partners Management Co now owns 91,100 shares of the company’s stock valued at $48,000 after acquiring an additional 74,108 shares during the last quarter. Hedge funds and other institutional investors own 2.84% of the company’s stock.

About NantHealth

NantHealth, Inc, together with its subsidiaries, operates as a healthcare technology company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solutions, including molecular profiling solutions, software, and hardware systems infrastructure, which integrates patient data management, bioinformatics, and molecular medicine to enable value-based care and evidence-based clinical practice.

Featured Story: What does relative strength index mean?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.